{"id":"https://openalex.org/W1551437481","doi":null,"title":"RESPONSE OF ANTI-CARDIOLIPIN ANTIBODIES TO VARIOUS TREATMENT MODALITIES IN GUILLAIN BARRE SYNDROME","display_name":"RESPONSE OF ANTI-CARDIOLIPIN ANTIBODIES TO VARIOUS TREATMENT MODALITIES IN GUILLAIN BARRE SYNDROME","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W1551437481","mag":"1551437481"},"language":"en","primary_location":{"id":"pmh:oai:ecite.utas.edu.au:95743","doi":null,"is_oa":false,"landing_page_url":"http://ecite.utas.edu.au/95743","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Refereed Article"},"parent_works":[],"lineage":["https://openalex.org/W1551437481"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003456931","display_name":"Hussein Hs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hussein Hs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041675268","display_name":"HA Al-Hamadani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"HA Al-Hamadani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058501606","display_name":"EA Al-Wasiti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"EA Al-Wasiti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048204657","display_name":"DA Jamil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"DA Jamil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078748374","display_name":"Hayder A. Al-Aubaidy","orcid":"https://orcid.org/0000-0001-9564-0120","observed_orcids":["https://orcid.org/0000-0001-9564-0120"]},"institutions":[{"id":"https://openalex.org/I153230381","display_name":"Charles Sturt University","ror":"https://ror.org/00wfvh315","country_code":"AU","type":"education","lineage":["https://openalex.org/I153230381"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hayder A. Al-Aubaidy","raw_affiliation_strings":["Charles Sturt University. ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles Sturt University. ,","institution_ids":["https://openalex.org/I153230381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"2","first_page":"1585","last_page":"1593"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticardiolipin-antibodies","display_name":"anticardiolipin antibodies","score":0.859000027179718},{"id":"https://openalex.org/keywords/guillain-barre-syndrome","display_name":"Guillain-Barr\u00e9 syndrome","score":0.9509999752044678},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.9850000143051147},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.9049999713897705},{"id":"https://openalex.org/keywords/autoimmunity","display_name":"autoimmunity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/cutoff-values","display_name":"cut-off values","score":0.515999972820282},{"id":"https://openalex.org/keywords/treatment-comparison","display_name":"treatment comparison","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C2778691916","wikidata":"https://www.wikidata.org/wiki/Q205214","display_name":"Guillain-Barre syndrome","level":2,"score":0.8540116548538208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8536422252655029},{"id":"https://openalex.org/C3018762881","wikidata":"https://www.wikidata.org/wiki/Q3774511","display_name":"Anticardiolipin antibodies","level":3,"score":0.7491678595542908},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6936184763908386},{"id":"https://openalex.org/C2781302388","wikidata":"https://www.wikidata.org/wiki/Q183453","display_name":"Cardiolipin","level":4,"score":0.581671416759491},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.48318496346473694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47350719571113586},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4533388912677765},{"id":"https://openalex.org/C2909916134","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulin Therapy","level":3,"score":0.4360584020614624},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4348728060722351},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:ecite.utas.edu.au:95743","doi":null,"is_oa":false,"landing_page_url":"http://ecite.utas.edu.au/95743","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Refereed Article"},{"id":"pmh:oai:figshare.com:article/22916672","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/Response_of_anti-cardiolipin_antibodies_to_various_treatment_modalities_in_guillain_barre_syndrome/22916672","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"mag:1551437481","doi":null,"is_oa":false,"landing_page_url":"http://ecite.utas.edu.au/95743/1/WJPR%20Anticardiolipin.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1987702880","https://openalex.org/W2021949020","https://openalex.org/W2023989401","https://openalex.org/W2025148770","https://openalex.org/W2035685706","https://openalex.org/W2040134794","https://openalex.org/W2068469174","https://openalex.org/W2072262051","https://openalex.org/W2088071042","https://openalex.org/W2088762395","https://openalex.org/W2128970512","https://openalex.org/W2152169495","https://openalex.org/W2163550872","https://openalex.org/W2167558846","https://openalex.org/W2318959418","https://openalex.org/W2410437176","https://openalex.org/W2414936685","https://openalex.org/W3148579587"],"related_works":["https://openalex.org/W2128970512","https://openalex.org/W2025148770","https://openalex.org/W2053129857","https://openalex.org/W2002197774","https://openalex.org/W2010303456","https://openalex.org/W1964555656","https://openalex.org/W2371410936","https://openalex.org/W4249648081","https://openalex.org/W3024314038"],"abstract_inverted_index":{"This":[0],"study":[1,51,148],"was":[2],"undertaken":[3],"to":[4,25,39,89,94,137,161,172],"investigate":[5],"the":[6,27,40,61,64,71,90,119,138,150,169,173,177,184],"presence":[7],"of":[8,14,34,42,99,118,153,180],"anticardiolipin":[9],"antibodies":[10,79,111,155],"in":[11,29,31,37,49,82,108,112,133,157,163],"serum":[12,32,109],"samples":[13,33],"Guillain":[15,164],"Barre":[16,165],"patients":[17,36,46,85,115,123,139,159],"not":[18],"previously":[19],"diagnosed":[20],"with":[21],"autoimmunity":[22],"disorder":[23],"and":[24,52,70,86,167],"examine":[26],"fluctuation":[28],"ACA":[30],"GBS":[35],"response":[38,160],"course":[41],"treatment.":[43,77,120],"Twenty":[44],"one":[45],"were":[47,53,80,87],"recruited":[48],"this":[50,134],"divided":[54],"into":[55],"2":[56],"main":[57],"groups":[58],"based":[59],"on":[60],"treatment":[62,162,181],"method,":[63],"first":[65],"group":[66,73,93],"received":[67,74,124,140],"plasma":[68,125,170],"exchange":[69,126,171],"second":[72],"intravenous":[75,141,174],"immunoglobulin":[76,142,175],"Anticardiolipin":[78,110],"assessed":[81],"all":[83,113],"our":[84,114],"compared":[88,136],"normal":[91],"control":[92],"establish":[95],"a":[96,105,129],"cut-off":[97],"value":[98],"10":[100],"U/ml.":[101],"The":[102,146],"results":[103],"showed":[104],"significant":[106,131],"reduction":[107,132],"after":[116],"starting":[117],"In":[121],"addition,":[122],"therapy":[127,143],"had":[128],"more":[130],"marker":[135],"at":[144],"p<0.05.":[145],"current":[147],"illustrate":[149],"beneficial":[151],"use":[152],"anti-cardiolipin":[154],"titre":[156],"monitoring":[158],"syndrome":[166],"favours":[168],"as":[176],"preferred":[178],"method":[179],"which":[182],"has":[183],"best":[185],"outcome.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1551437481","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
